Translational Development (TDAC)
Translational Development Acquisition Corp. is a NASDAQ-listed common stock company with no significant operating business at present. The company was formed in 2022 and is based in New York, New York. It is organized to pursue a business combination such as a merger, share exchange, asset acquisition, reorganization, or a similar transaction with one or more businesses.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | P/E Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-TDAC
|
$10.72
|
-1.2% Downside
|
Fair
|
Not available
|
Not available
|
Fair
|
0.0%
|
40.5x
|
242.7 M
|
225 M
|
0.5%
|
77.6%
|
0.8
|
-15.3%
|
